Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation
JACC: Cardiovascular Interventions · 2024-11 · 17 (21) · 2543-2554
DOI: 10.1016/j.jcin.2024.08.016 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2024-11. Verfasst von Thomas J Stocker und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Department of Medicine I, LMU University Hospital, Ludwig Maximilian University of Munich, Munich, Germany; German Center f…. Hauptthemen laut MEDLINE: Cardiac Catheterization, Heart Valve Prosthesis Implantation, Mitral Valve, Mitral Valve Insufficiency. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Mitral valve transcatheter edge-to-edge repair (M-TEER) reduces secondary mitral regurgitation (MR) in heart failure and impacts survival in selected patients as demonstrated in the COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial. However, long-term outcome data after M-TEER under real-world conditions are lacking. OBJECTIVES: This study sought to assess long-term efficacy and survival after M-TEER in a large real-world registry. METHODS: We analyzed patients with significant secondary MR undergoing M-TEER from the EuroSMR (European Registry of Transcatheter Repair for Secondary Mitral Regurgitation) registry. Long-term MR reduction, functional outcomes, survival rate, and predictors for all-cause mortality were assessed. RESULTS: In this study, 1,628 patients undergoing M-TEER (mean age 73.8 years, mean EuroSCORE II [European System for Cardiac Operative Risk Evaluation II] 6.9%, 86.6% NYHA functional class ≥III) with available long-term data were included. Five-year survival was 35.0%. Long-term MR reduction (MR grade ≤2+: baseline 4.1%, discharge 92.2%, 5-year follow-up 85.5%; P < 0.001) and functional improvement (NYHA ≤II: baseline 13.4%, 5-year follow-up 60.1%; P < 0.001) was observed. The degree of residual MR was associated with 5-year survival (residual MR grade ≤1+: 38.6%; 2+: 30.5%; ≥3+: 22.6%; P < 0.001). Independent predictors for 5-year all-cause mortality post-M-TEER included age, renal function, residual MR, NYHA functional class, left ventricular ejection-fraction, and COAPT trial eligibility (P < 0.01 for all). CONCLUSIONS: This extensive multicenter registry underscores the long-term efficacy of M-TEER in real-world clinical practice and identifies predictors for long-term survival. These findings contribute valuable insights for optimizing patient selection in routine clinical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Department of Medicine I, LMU University Hospital, Ludwig Maximilian University of Munich, Munich, Germany; German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich…
- Department of Cardiology, Department of Medicine I, LMU University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.
- Department of Cardiology, European Hospital Georges Pompidou, Paris, France.
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Hamburg,…
- German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany; Department of Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany.
- Cardiac Catheterization Laboratory and Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Zitieren
APA
Stocker, T. J., Stolz, L., Karam, N., Kalbacher, D., Koell, B., Trenkwalder, T., Xhepa, E., Adamo, M., Spieker, M., Horn, P., Butter, C., Weckbach, L. T., Novotny, J., Melica, B., Giannini, C., von Bardeleben, R. S., Pfister, R., Praz, F., Lurz, P., …, & EuroSMR Investigators (2024). Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation. JACC: Cardiovascular Interventions, 17(21), 2543-2554. https://doi.org/10.1016/j.jcin.2024.08.016
Vancouver
Stocker TJ, Stolz L, Karam N, Kalbacher D, Koell B, Trenkwalder T, et al. Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation. JACC: Cardiovascular Interventions. 2024;17(21):2543-2554. doi:10.1016/j.jcin.2024.08.016
BibTeX
@article{Stocker2024,
author = {Stocker, Thomas J and Stolz, Lukas and Karam, Nicole and Kalbacher, Daniel and Koell, Benedikt and Trenkwalder, Teresa and Xhepa, Erion and Adamo, Marianna and Spieker, Maximilian and Horn, Patrick and Butter, Christian and Weckbach, Ludwig T and Novotny, Julia and Melica, Bruno and Giannini, Christina and von Bardeleben, Ralph Stephan and Pfister, Roman and Praz, Fabien and Lurz, Philipp and Rudolph, Volker and Metra, Marco and Hausleiter, Jörg and EuroSMR Investigators, EuroSMR Investigators},
title = {Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {21},
pages = {2543--2554},
doi = {10.1016/j.jcin.2024.08.016}
}
EUVIMED